Abstract Library

#1765 Management of MEN1 Related Non-Functioning Pancreatic NETs: A Shifting Paradigm. Results from the Dutch MEN1 Study Group

Introduction: The evidence base when to operate MEN1 related non-functioning pancreatic neuroendocrine tumors (NF-pNETs) is meager.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Nell S

Authors: Nell S, Verkooijen H, Pieterman C, de Herder W, Hermus A,

Keywords: MEN1,

#666 Ability of Tumor Markers for Predicting Future Metastatic Disease in MEN-1 Patients with a Pancreatic Neuroendocrine Tumor

Introduction: The diagnostic value of tumor markers in the follow-up of MEN-1 patients with a pancreatic neuroendocrine tumor (pNET) is unclear.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: De Laat J, Pieterman C, Twisk J, Hermus A, Dekkers O,

Keywords: MEN-1, tumor marker, pNET, SSA,

#664 Natural Course and Survival of Thymic and Bronchopulmonary Neuroendocrine Tumors are Different for Male and Female MEN-1 Patients

Introduction: The course of thymic- and bronchopulmonary neuroendocrine tumors (Th- and Bp-NET) in MEN-1 patients is still unclear.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: De Laat J, Pieterman C, Twisk J, Hermus A, Dekkers O,

Keywords: MEN-1, lung NET, thymic NET, natural course, survival,

#442 Low Diagnostic Accuracy of Tumor Markers for the Annual Screening of Pancreatic Neuroendocrine Tumors in MEN-1 Patients

Introduction: The use of tumor markers for annual screening for pancreatic neuroendocrine tumors (pNET) in Multiple Endocrine Neoplasia type 1 (MEN-1) is debatable because of low-level evidence and high costs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: De Laat J, Weijmans M, Hermus A, Dekkers O, De Herder W,

Keywords: MEN-1, tumor marker, annual screening, Chromogranin A,